Tag archives: pharmaceutical

Revisions to PRC Medical Devices Regulations

By Justin Davidson (HK) and Stanley Ng on April 8, 2021 Posted in General

The PRC Regulations on the Supervision and Administration of Medical Devices (“Regulations”) have recently been amended and promulgated by the State Council. The new Regulations, which will be effective from 1st June 2021, provide some important changes of which the medical device industry should be aware. Under the current Regulations, a license to manufacture medical … Continue reading

2020 Year in Review – PRC Patent Laws and Practices

By Justin Davidson (HK) and Stanley Ng on February 4, 2021 Posted in Intellectual Property, Patents

2020 was a year of change and challenge. This holds true not only for the way we live and work, but also in relation to the patent laws and practices in the People’s Republic of China (“PRC”). In the last year, a number of significant amendments affecting various aspects of patent prosecution and enforcement were … Continue reading

China’s 2020 Patent Law Reform and Patent Linkage System

By Justin Davidson (HK) and Stanley Ng on November 26, 2020 Posted in Patents

Patent Law Reform We discussed the second draft of proposed amendments to the People’s Republic of China (“PRC”) Patent Law in our previous blog post here. Since then, on 17 October 2020 the PRC National People’s Congress (“NPC”) approved most of the amendments, though the law as passed is different from the draft in two … Continue reading

China Releases Draft Patent Law Amendment

By Justin Davidson (HK) and Stanley Ng on July 24, 2020 Posted in Patents

On 3rd July 2020, the National People’s Congress (NPC) of the People’s Republic of China released a second draft of proposed amendments to the PRC Patent Law for public consultation. In response to opinions from various government authorities and experts, the second draft incorporates several important changes of note: Partial design protection The draft includes … Continue reading

Australia – No extensions for Swiss style Pharma Patents

By Helen Macpherson (AU) and Rohan Sridhar (AU) on August 31, 2017 Posted in Advertising, General

A Full Court of the Federal Court has confirmed that patents containing “Swiss-style” claims are outside the scope of the Australian patent term extension regime in its recent judgment of Commissioner of Patents v AbbVie Biotechnology Ltd [2017] FCAFC 129. What it means: Patents which claim methods or processes involving pharmaceutical substances cannot be extended … Continue reading